Genome-wide association analysis identifies 13 new risk loci for schizophrenia

Date

2013

Authors

Ripke, S.
O'Dushlaine, C.
Chambert, K.
Moran, J.L.
Lee, S.H.
Sullivan, P.F.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

Nature Genetics, 2013; 45(10):1150-1159

Statement of Responsibility

Conference Name

Abstract

Schizophrenia is an idiopathic mental disorder with a heritable component and a substantial public health impact. We conducted a multi-stage genome-wide association study (GWAS) for schizophrenia beginning with a Swedish national sample (5,001 cases and 6,243 controls) followed by meta-analysis with previous schizophrenia GWAS (8,832 cases and 12,067 controls) and finally by replication of SNPs in 168 genomic regions in independent samples (7,413 cases, 19,762 controls and 581 parent-offspring trios). We identified 22 loci associated at genome-wide significance; 13 of these are new, and 1 was previously implicated in bipolar disorder. Examination of candidate genes at these loci suggests the involvement of neuronal calcium signaling. We estimate that 8,300 independent, mostly common SNPs (95% credible interval of 6,300-10,200 SNPs) contribute to risk for schizophrenia and that these collectively account for at least 32% of the variance in liability. Common genetic variation has an important role in the etiology of schizophrenia, and larger studies will allow more detailed understanding of this disorder.

School/Discipline

Dissertation Note

Provenance

Description

Data source: Supplementary information, https://doi.org/10.1038/ng.2742 Link to a related website: http://europepmc.org/articles/pmc3827979?pdf=render, Open Access via Unpaywall

Access Status

Rights

Copyright 2013 Nature America

License

Grant ID

Call number

Persistent link to this record